Shopping Cart 0
Cart Subtotal
AED 0

Epizyme Inc (EPZM) - Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

Epizyme Inc (EPZM)-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

Epizyme, Inc. (Epizyme) is a biopharmaceutical company that develops novel epigenetic therapies for the treatment of cancer and other disorders. Its lead product candidate tazemetostat is a first-in-class EZH2 inhibitor finds application in hematological malignancies and solid tumors as a monotherapy and combination therapy in relapsed or refractory non-Hodgkin lymphoma. The company's other pipeline products include EZM8266 for sickle cell disease; protein arginine methyltransferase (PRMT) inhibitors for solid tumors, B- cell lymphoma and blood cancer; Pinometostat for acute leukemia. The company develops products through proprietary drug discovery platform and collaborations with other companies. Epizyme is headquartered in Cambridge, Massachusetts, the US.

Epizyme Inc Key Recent Developments

Aug 09,2019: Epizyme reports business progress and second quarter 2019 results

Jul 22,2019: Epizyme strengthens leadership team with appointment of Paolo Tombesi as chief financial officer

May 06,2019: Epizyme provides business update and reports first quarter 2019 financial results

Feb 26,2019: Epizyme provides business update and reports fourth quarter and full year 2018 financial results

Nov 19,2018: Boehringer partners with Epizyme to develop new cancer therapies

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Epizyme Inc-Key Facts

Epizyme Inc-Key Employees

Epizyme Inc-Key Employee Biographies

Epizyme Inc-Major Products and Services

Epizyme Inc-History

Epizyme Inc-Company Statement

Epizyme Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Epizyme Inc-Business Description

R&D Overview

Epizyme Inc-Corporate Strategy

Epizyme Inc-SWOT Analysis

SWOT Analysis-Overview

Epizyme Inc-Strengths

Epizyme Inc-Weaknesses

Epizyme Inc-Opportunities

Epizyme Inc-Threats

Epizyme Inc-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Epizyme Inc, Recent Deals Summary

Section 4-Company's Recent Developments

Aug 09, 2019: Epizyme reports business progress and second quarter 2019 results

Jul 22, 2019: Epizyme strengthens leadership team with appointment of Paolo Tombesi as chief financial officer

May 06, 2019: Epizyme provides business update and reports first quarter 2019 financial results

Feb 26, 2019: Epizyme provides business update and reports fourth quarter and full year 2018 financial results

Nov 19, 2018: Boehringer partners with Epizyme to develop new cancer therapies

Nov 02, 2018: Epizyme reports third quarter 2018 financial results and Tazemetostat progress

Aug 02, 2018: Epizyme reports second quarter 2018 financial results and provides business updates

Jul 23, 2018: Epizyme names Dr. Shefali Agarwal as Chief Medical Officer

May 08, 2018: Epizyme Reports First Quarter 2018 Financial Results and Provides Business Updates

Mar 13, 2018: Epizyme Reports Fourth Quarter and Full Year 2017 Financial Results

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Epizyme Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Epizyme Inc, Key Facts

Epizyme Inc, Key Employees

Epizyme Inc, Key Employee Biographies

Epizyme Inc, Major Products and Services

Epizyme Inc, History

Epizyme Inc, Subsidiaries

Epizyme Inc, Key Competitors

Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Epizyme Inc, Recent Deals Summary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Epizyme Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Takeda Pharmaceutical Co Ltd

Pfizer Inc

Novartis AG

Merck & Co Inc

Eisai Inc

Daiichi Sankyo Co Ltd

Constellation Pharmaceuticals Inc

Celgene Corp

Company Profile

Company Profile Title

Epizyme Inc (EPZM)-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

Epizyme, Inc. (Epizyme) is a biopharmaceutical company that develops novel epigenetic therapies for the treatment of cancer and other disorders. Its lead product candidate tazemetostat is a first-in-class EZH2 inhibitor finds application in hematological malignancies and solid tumors as a monotherapy and combination therapy in relapsed or refractory non-Hodgkin lymphoma. The company's other pipeline products include EZM8266 for sickle cell disease; protein arginine methyltransferase (PRMT) inhibitors for solid tumors, B- cell lymphoma and blood cancer; Pinometostat for acute leukemia. The company develops products through proprietary drug discovery platform and collaborations with other companies. Epizyme is headquartered in Cambridge, Massachusetts, the US.

Epizyme Inc Key Recent Developments

Aug 09,2019: Epizyme reports business progress and second quarter 2019 results

Jul 22,2019: Epizyme strengthens leadership team with appointment of Paolo Tombesi as chief financial officer

May 06,2019: Epizyme provides business update and reports first quarter 2019 financial results

Feb 26,2019: Epizyme provides business update and reports fourth quarter and full year 2018 financial results

Nov 19,2018: Boehringer partners with Epizyme to develop new cancer therapies

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Epizyme Inc-Key Facts

Epizyme Inc-Key Employees

Epizyme Inc-Key Employee Biographies

Epizyme Inc-Major Products and Services

Epizyme Inc-History

Epizyme Inc-Company Statement

Epizyme Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Epizyme Inc-Business Description

R&D Overview

Epizyme Inc-Corporate Strategy

Epizyme Inc-SWOT Analysis

SWOT Analysis-Overview

Epizyme Inc-Strengths

Epizyme Inc-Weaknesses

Epizyme Inc-Opportunities

Epizyme Inc-Threats

Epizyme Inc-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Epizyme Inc, Recent Deals Summary

Section 4-Company's Recent Developments

Aug 09, 2019: Epizyme reports business progress and second quarter 2019 results

Jul 22, 2019: Epizyme strengthens leadership team with appointment of Paolo Tombesi as chief financial officer

May 06, 2019: Epizyme provides business update and reports first quarter 2019 financial results

Feb 26, 2019: Epizyme provides business update and reports fourth quarter and full year 2018 financial results

Nov 19, 2018: Boehringer partners with Epizyme to develop new cancer therapies

Nov 02, 2018: Epizyme reports third quarter 2018 financial results and Tazemetostat progress

Aug 02, 2018: Epizyme reports second quarter 2018 financial results and provides business updates

Jul 23, 2018: Epizyme names Dr. Shefali Agarwal as Chief Medical Officer

May 08, 2018: Epizyme Reports First Quarter 2018 Financial Results and Provides Business Updates

Mar 13, 2018: Epizyme Reports Fourth Quarter and Full Year 2017 Financial Results

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Epizyme Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Epizyme Inc, Key Facts

Epizyme Inc, Key Employees

Epizyme Inc, Key Employee Biographies

Epizyme Inc, Major Products and Services

Epizyme Inc, History

Epizyme Inc, Subsidiaries

Epizyme Inc, Key Competitors

Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Epizyme Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Epizyme Inc, Recent Deals Summary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Epizyme Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Takeda Pharmaceutical Co Ltd

Pfizer Inc

Novartis AG

Merck & Co Inc

Eisai Inc

Daiichi Sankyo Co Ltd

Constellation Pharmaceuticals Inc

Celgene Corp